fbpx

Nutrition and Hydration for long-term care-Tuesday Tube Facts

Did you know…?

Long term care residents nutrition and hydration statuses are tracked by state and federal surveyors. Elderly population malnutrition is associated with poor clinical outcomes and increased mortality.[1]

Residents with severe malnutrition are also at increased risk for developing a number of chronic medical conditions.[1]

References:

  1. Carlson, RD , Deirdre, and Anita Kilmanis, RD, LDN. “What Long Term Care Dietitians Need To Know About the MDS 3.0: Dietitians On Demand.” Dietitians On Demand | Professional Recruiting Services for Contract and Permanent-Hire Positions., 30 Mar. 2021, dietitiansondemand.com/what-long-term-care-dietitians-need-to-know-about-the-mds-3-0/.

BTF for adult patients-Tuesday Tube Facts

Did you know…?

Common indications for Blenderized Tube Feeding (BTF) with adult patients typically includes patients who are expected to be on tube feeding long term.[1]

Typical conditions/disease states include, Oncology, Stroke, ALS, Dysphagia, and TBI. BTF is commonly used in Acute Care, Post Acute Care, and Outpatient settings.[3]

References:

1. Johnson , Teresa, director. Blenderized Tube Feeding for Adult Enteral Nutrition Patients. YouTube, ASPEN , 3 Nov. 2020.                                                       

  1.                 www.youtube.com/watch?v=TX1lVPWQk_w&t=1s. 

Malnutrition Increases LOS-Tuesday Tube Facts

Did you know…?

Patients with malnutrition had 3 times greater length of stay and costs than patients who did not have a malnutrition diagnosis.[1]

References:

  1. Corkins, M., Guenter, P., DiMario-Ghalili, R., Jensen, G., Malone, A., Miller, S., Patel, V., Plogsted, S., Resnick, H. Malnutrition Diagnoses in Hospitalized Patients. Journal of Pareneteral and Enteral Nutrition. 2014. 38(2): 186-195.

TubeClear Receives FDA Clearance for New GJ-Specific Clearing Stem Model

TubeClear Receives FDA Clearance for New GJ-Specific Clearing Stem Model

BELLEFONTE, PA – Actuated Medical, Inc. (AMI) recently received its sixth Food and Drug Administration (FDA) 510(k) clearance for the TubeClear® system. Clearance number K200646 introduces a Clearing Stem model that is compatible with select gastro-jejunostomy (GJ) feeding tubes.

These complex dual lumen feeding tubes are often expensive and require surgery to place. When a clogged feeding tube of any type cannot be cleared, it requires replacement. The new TubeClear GJ-1422 Clearing Stem offers a mechanical option for clinicians to keep these expensive GJ tubes clear and avoid an unnecessary procedure to replace the tube. The GJ-1422 Clearing Stem is designed to work with MIC*, MIC-KEY* (Avanos Medical, Inc., Alpharetta, GA) and G-Jet® (Applied Medical Technology (AMT), Brecksville, OH) GJ feeding tubes that are 14-22 French diameter and have a jejunal length of 15-45 centimeters.

“Clogging in GJ tubes is one of the most common complaints we hear from clinicians and patients alike,” said AMI president and chief executive officer Maureen L. Mulvihill, PhD. “Being able to deliver a Clearing Stem that is compatible with our existing TubeClear system as well as GJ feeding tubes is an exciting opportunity for AMI to support vulnerable patients and improve their outcomes.”

The TubeClear system is an FDA cleared medical device that uses patented mechanical motion technology to maintain flow and clear clogs in most feeding and decompression tubes while the tube remains in the patient and works at bedside. Keeping these tubes clear prevents interruptions to feeding and medication delivery, allowing clinicians to maintain their focus on improving patient care and reducing healthcare cost associated with tube replacement. The system, which is comprised of reusable control boxes and single-use clearing stems, is designed, developed, and manufactured by AMI in Bellefonte, PA. The new GJ Clearing Stem is slated to be available for sale in clinical settings in early 2021.

 

***

About Actuated Medical, Inc.

Actuated Medical develops medical devices that integrate electronically controlled motion technologies that improve patient outcomes and reduce healthcare costs. Their development process focuses on intellectual property, regulatory, and reimbursement strategies to decrease commercialization risk and attract medical device technology licensing partnerships. Their devices solve unmet clinical needs in target markets (e.g., GI, oncology, critical care and pediatrics). Actuated Medical a certified women-owned business located in Bellefonte, PA and is ISO 13485:2016 certified.

For more information, please visit http://www.actuatedmedical.com